The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030
Roots Analysis is pleased to announce the publication of its recent study,titled “Subcutaneous Biologics,Technologies and Drug Delivery Systems (3rd Edition), 2020-2030” report to itslist of offerings.
Thereport provides a detailed study on the current market landscape and futurepotential of biologics designed for subcutaneous administration. In addition,the study provides an in-depth analysis of the formulation technologies anddrug delivery systems (focusing on large volume wearable injectors,autoinjectors, pen injectors, needle-free injectors, drug reconstitutionsystems, prefilled syringes and implants) that enable subcutaneous delivery ofthe biologic drugs. Amongst other elements, the report features the following:
§ A detailed assessment of the current market landscape ofcommercially available and clinical-stage biologics that are designed fordelivery via the subcutaneous route
§ Acase study on leading subcutaneous biologics (in terms of revenues generated),featuring details on mechanism of action, development history, annual sales,technology platform (if available), and a comparison of their intravenous andsubcutaneous formulations (if applicable).
§ Anassessment of the various subcutaneous formulation technologies along withinformation on developers, type of pharmacological molecule, route ofadministration, mechanisms of action and primary advantage(s).
§ Aninsightful three-dimensional comparison of the subcutaneous formulationtechnology developers, based on pipeline strength, supplier power of thedeveloper and primary advantages offered by their respective technologies.
§ Elaborateprofiles of key technology developers, featuring a brief overview of the company,its technology portfolio, product portfolio, financial information (ifavailable), recent developments and an informed future outlook.
§ Ananalysis of collaborations andpartnership agreements inked by the subcutaneous formulation technologydevelopers since 2011
§ Anin-depth review of the most advanced and popular subcutaneous drug deliverysystems, including large volume wearable injectors, autoinjectors, peninjectors, needle-free injectors, drug reconstitution systems, prefilledsyringes and implants
§ Acomprehensive product competitiveness analysis of subcutaneous large volumewearable injectors, subcutaneous autoinjectors, subcutaneous needle-freeinjectors and pre-filled syringes
§ Adiscussion on affiliated trends, key drivers and challenges, which are likelyto impact the industry's evolution, under a comprehensive SWOT framework
§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow):
§ Phaseof development
§ Approved
§ Pre-registration & Phase III
§ Phase II & Phase II/III
To request a customize report – https://www.rootsanalysis.com/reports/314/request-customization.html
§ Typeof molecule
§ Cell and gene therapies
§ Monoclonal antibodies
§ Proteins
§ Peptides (recombinant)
§ Vaccines
§ Others
§ Targettherapeutic area
§ Autoimmune disorders
§ Blood disorders
§ Bone disorders
§ Genetic disorders
§ Metabolic disorders
§ Neurological disorders
§ Oncological disorders
§ Respiratory disorders
§ Others
§ Typeof drug delivery system
§ Large volume wearable injectors
§ Autoinjectors
§ Prefilled syringes
§ Needle-free injectors
§ Drug reconstitution systems
§ Revenuesfrom licensing deals
§ Upfront payments
§ Milestone payments
§ Keygeographical regions
§ North America
§ Europe
§ Asia Pacific
§ Rest of the World
To request a sample report - https://www.rootsanalysis.com/reports/subcutaneous-biologics-delivery/request-sample.html
Keycompanies covered in the report
§ Adocia
§ AjinomotoBio-Pharma Services
§ Arecor
§ Alteogen
§ AscendisPharma
§ AvadelPharmaceuticals
§ Camurus
§ CreativeBioMart
§ CreativeBiolabs
§ DURECT
§ EaglePharmaceuticals
§ HalozymeTherapeutics
§ MedinCell
§ XerisPharmaceuticals
§ SerinaTherapeutics
For additionaldetails, please visit
https://www.rootsanalysis.com/reports/view_document/subcutaneous-biologics-delivery/314.html
1. Global AutoinjectorsMarket(3rd Edition), 2020-2030
2. Prefilled SyringesMarket(5th Edition), 2020-2030
3. Microneedles and Needle-Free Injection Systems
4. ChinaBiopharmaceutical Contract Manufacturing Market, 2020 – 2030
5. HPAPI and CytotoxicDrugs Manufacturing Market (3rd Edition), 2020-2030
6. Novel coronavirus(COVID-19): Preventive Vaccines, Therapeutics and Diagnostics in Development
About Roots Analysis
RootsAnalysis is one of the fastest growing market research companies, sharing freshand independent perspectives in the bio-pharmaceutical industry. The in-depth research,analysis and insights are driven by an experienced leadership team which hasgained many years of significant experience in this sector. If you’d like helpwith your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
GauravChaudhary
+1(415) 800 3415
Facebook- https://www.facebook.com/RootsAnalysis
LinkedIn- https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter- https://twitter.com/RootsAnalysis
